Key Segments:
By Phase
-
- Clinical
- Phase I
- Phase II
- Phase III
- Phase IV
- Preclinical
- Clinical
By Application
-
- Oncology
- Rare Diseases
- Infectious Diseases
- Others
By Service
-
- Contract Manufacturing
- Contact Development
By Type
-
- Inhibitor Drugs
- Monoclonal Antibodies
- Cell & Gene Therapy
- Others
By End Use
-
- Pharmaceutical Companies
- Biotechnology Companies
- Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
- US
- Canada
Europe
- Germany
- France
- UK
- Italy
- Spain
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- ASEAN Countries
- Rest of Asia Pacific
Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- Egypt
- South Africa
- Rest of Middle East & Africa
Latin America
- Brazil
- Argentina
- Mexico
- Colombia
- Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
- Detailed Volume Analysis
- Criss-Cross segment analysis (e.g., Product X Application)
- Competitive Product Benchmarking
- Geographic Analysis
- Additional countries in any of the regions
- Customized Data Representation
- Detailed analysis and profiling of additional market players
Frequently Asked Questions
North America dominated the personalized medicine outsourcing market in 2024.
The “clinical” segment dominated the personalized medicine outsourcing market.
The high cost and complex nature of personalized medicine R&D to be conducted in-house have accelerated the market growth.
The personalized medicine outsourcing market was USD 109.88 billion in 2024 and is expected to reach USD 281.72 billion by 2032.
The personalized medicine outsourcing market is expected to grow at a CAGR of 12.54% from 2025 to 2032.